詳細
Purified mouse monoclonal antibody derived by immunizing BALB/c mice with the specified immunogen and fusing splenocytes with SP2/0 mouse myeloma cells. Recognizes N-myc as well as its cleavage products.
Recognizes N-myc as well as its cleavage products in IMR5 cells. Myc is a labile protein. Fresh lysates in the presence of protease inhibitor cocktails are recommended.
The v-myc oncogene, initially identified in the MC29 avian retrovirus, causes myelocytomas, carcinomas, sarcomas and lymphomas, and belongs to a family of oncogenes conserved throughout evolution. In humans the family consists of five genes: c-myc, N-myc, R-myc, L-myc and B-myc. Amplification of the N-myc gene has been found in human neuroblastomas and cell lines. The extent of N-myc amplification correlates well with the stage of neuroblastoma disease. Immunological studies have shown that the human N-myc gene gives rise to at least two nuclear phosphoproteins of ~64 kDa and ~67 kDa that exhibit relatively short (30 min) half lives in vivo and exhibit DNA binding properties in vitro.
免疫原
recombinant, human, N-Myc fusion protein, expressed in E. coli
アプリケーション
Frozen Sections (1-5 μg/ml)
Immunoblotting (1-5 μg/ml, see application references)
Immunofluorescence (1-5 μg/ml, see application references)
Immunoprecipitation (1-2 μg/sample, see application references)
Immunoblotting (1-5 μg/ml, see application references)
Immunofluorescence (1-5 μg/ml, see application references)
Immunoprecipitation (1-2 μg/sample, see application references)
物理的形状
Lyophilized from a volatile buffer, 100 μg BSA.
再構成
Reconstitute the lyophilized antibody with 1 ml sterile PBS. Lyophilized antibodies should be reconstituted at 4°C with occasional gentle mixing for at least 2 h. Following reconstitution, refrigerate (4°C) for short-term storage or aliquot and freeze (-2
アナリシスノート
Positive Control
IMR5 cells
IMR5 cells
その他情報
It is important to compensate for the short half life of this protein when preparing tissue sections or extracts. We recommended that all preparations be kept cold and that a cocktail of protease inhibitors be used. Antibody should be titrated for optimal
保管分類コード
10-13 - German Storage Class 10 to 13
試験成績書(COA)
製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
The myc oncogene: its role in transformation and differentiation.
Annual review of genetics, 20, 361-384 (1986-01-01)
Science (New York, N.Y.), 232(4751), 768-772 (1986-05-09)
The human N-myc gene is related to the c-myc proto-oncogene, and has been shown to have transforming potential in vitro. Many studies have reported amplification of N-myc in human neuroblastoma and retinoblastoma cell lines. In primary tumors, amplification of the
The New England journal of medicine, 313(18), 1111-1116 (1985-10-31)
Eighty-nine patients with untreated primary neuroblastomas were studied to determine the relation between the number of copies of the N-myc oncogene and survival without disease progression. Genomic amplification (3 to 300 copies) of N-myc was detected in 2 of 16
Oncogene, 6(7), 1269-1276 (1991-07-01)
The N-myc gene is amplified in several types of human tumors. To assess the role of the N-myc gene in the transformation of normal human cells, we transfected an N-myc expression vector into diploid human fibroblasts. Transfected clones were isolated
Proceedings of the National Academy of Sciences of the United States of America, 83(16), 5929-5933 (1986-08-01)
Increased N-myc (now designated NMYC in human gene nomenclature) gene expression has been detected at the transcriptional level in certain types of neoplasms. As yet, the N-myc gene product has not been identified. To detect and characterize the N-myc gene
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら(テクニカルサービス)